AbbVie Revenue Rises on Strength in Immunology, Neuroscience

AbbVie Revenue Rises on Strength in Immunology, Neuroscience

来源:WSJ发布于 2026-10-30

The pharmaceutical company boosted its profit outlook for the year, and raised its quarterly dividend as both third-quarter results and full-year guidance came in above expectations.

相关标的:ABBV

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。